Helus Pharma HELP
NASDAQ HELP
$10.36 +0.17 (+1.67%)
At close: Oct 26, 2026 · 4:00 PM EDT

Helus Pharma (HELP) EBITDA (2020 - 2021)

Updated

Cybin (HELP) recorded EBITDA of -$63.7 million in FY2022 (year ended Mar 31, 2022), compared with -$23.07 million in FY2021.

Analysis

Helus Pharma (HELP) EBITDA (2020 - 2021) Analysis & Trends

  • Per Business Quant data, HELP's EBITDA was -$23.07 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Bhp 200.99 Bn 144.17 Bn - -
2 Bank Of Nova Scotia 115.36 Bn -316.04 Bn - 7.07 Bn
3 Nokia 49.56 Bn 49.56 Bn 2.58 Bn -
4 Haleon 45.66 Bn 39.36 Bn - -
5 Gold Fields 31.50 Bn 28.42 Bn - -
6 Smith & Nephew 26.74 Bn 24.14 Bn - -
7 Sprott Physical Gold Trust 14.42 Bn 14.28 Bn - -
8 Magnum Ice Cream 11.88 Bn 10.57 Bn - -
9 Sprott Physical Silver Trust 10.62 Bn 10.29 Bn - -
10 Helus Pharma 534.91 Mn -67.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -9.74 Mn
Dec 31, 2020 -8.72 Mn
API Access

Helus Pharma EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=HELP&period=max&api_key=YOUR_API_KEY